This anti-inflammatory drug can reduce the risk of a heart attack

 
Related

Be careful! Salmonella outbreak linked to papayas spreads

Health at home
288 points

FDA proposes reducing nicotine in cigarettes

Health at home
212 points



Most recent

A man fakes his death to catch his murderer...his wife

Amazing histories
60 points

Facundo Moyano dice que quiere ser presidente de la Nación

sinfiltro
20 points

Thousands of scientists warn about the next mass extinction

You have to know
162 points

Guillermo Moreno admite que el Indec media mal la inflación

sinfiltro
20 points

Researchers create a brain implant that increases memory

Technology news
118 points
SHARE
TWEET
Canakinumab, reduces the danger of a second attack by 15%. This anti-inflammatory drug could reduce the risk of a heart attack.

This anti-inflammatory drug can reduce the risk of a heart attack

The link between inflammation and the formation of plaques in the arteries that can lead to a heart attack has long been observed. A clinical trial of more than 10,000 patients in 40 countries has shown that an anti-inflammatory drug can reduce cardiovascular risk regardless of cholesterol level.

Canakinumab was initially developed against arthritis. The research gave the result: patients treated not only had their arteries clearer, they also had fewer cases of lung cancer than those who received a placebo substance.

Each dose of the drug that Novartis has developed costs $ 16,000 per dose, which is given by intravenous infusion. In addition, there is a 1% chance that this anti-inflammatory drug will produce a fatal infection, especially among elderly patients and diabetes. Physicians should still assess the benefits and risks of treatment.

It is probably decided to book this treatment for the most at risk patients.

Fuente: www.adn40.mx
SHARE
TWEET
To comment you must log in with your account or sign up!
Featured content